ASCO: Cancer trials should take steps to assesses ovarian toxicity
ASCO: Cancer trials should take steps to assesses ovarian toxicity
About this item
Full title
ASCO: Cancer trials should take steps to assesses ovarian toxicity
Author / Creator
Publisher
Thorofare: Slack, Inc
Journal title
HEM/ONC today, 2024-01, Vol.25 (1), p.3-3
Language
English
Formats
Publication information
Publisher
Thorofare: Slack, Inc
Subjects
More information
Scope and Contents
Contents
[...]we do not know if newer cancer treatments, such as immunotherapy, cause ovarian toxicity," Wanda Cui, MBBS, BMedSci, FRACP, con sultant medical oncologist in the breast cancer and lung cancer service at Peter MacCallum Cancer Centre and lead author of the research statement, told Healio | HemOnc Today. The recommendations serve as a framework...
Alternative Titles
Full title
ASCO: Cancer trials should take steps to assesses ovarian toxicity
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3031033849
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3031033849
Other Identifiers
ISSN
1526-0488
How to access this item
Log in as a Library member
